The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 18, 2023

Filed:

Apr. 06, 2020
Applicants:

Boehringer Ingelheim Animal Health Usa Inc., Duluth, GA (US);

Iowa State University Research Foundation, Inc., Ames, IA (US);

Inventors:

Arun Iyer, Ames, IA (US);

Luis Alejandro Hernandez, Ames, IA (US);

Abby Patterson, Story City, IA (US);

Bailey Arruda, Ames, IA (US);

Luis Gabriel Gimenez-Lirola, Ames, IA (US);

Dave Michael Anstrom, Ames, IA (US);

Eric M. Vaughn, Ames, IA (US);

Pablo E. Pineyro Pineiro, Ames, IA (US);

Troy James Kaiser, Dearborn, MO (US);

Joseph Ralph Hermann, Waukee, IA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/23 (2006.01); A61P 31/20 (2006.01); A61P 37/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 39/23 (2013.01); A61P 31/20 (2018.01); A61P 37/04 (2018.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01); A61K 2039/70 (2013.01); C12N 2750/10034 (2013.01); C12N 2750/10071 (2013.01); C12N 2750/14034 (2013.01);
Abstract

The present invention relates to the use of an immunogenic composition that comprises a porcinetype 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.


Find Patent Forward Citations

Loading…